Cargando…

Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study

Introduction and Aims: HCV eradication by direct-acting antivirals (DAAs) improves liver outcomes and reduces overall liver mortality. However, patients with advanced chronic liver disease (ACLD) may experience a progression of liver disease despite viral clearance. Silybin has shown hepatoprotectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cossiga, Valentina, Sanduzzi-Zamparelli, Marco, Sapena, Victor, Guarino, Maria, Dallio, Marcello, Torrisi, Emanuele, Pignata, Luca, Federico, Alessandro, Salomone, Federico, Morisco, Filomena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847679/ https://www.ncbi.nlm.nih.gov/pubmed/35185575 http://dx.doi.org/10.3389/fphar.2022.824879

Ejemplares similares

Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
por: Federico, Alessandro, et al.
Publicado: (2019)

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
por: Federico, Alessandro, et al.
Publicado: (2017)

Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study
por: Morisco, Filomena, et al.
Publicado: (2021)

Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions
por: Cossiga, Valentina, et al.
Publicado: (2023)

Use of Telemedicine for Chronic Liver Disease at a Single Care Center During the COVID-19 Pandemic: Prospective Observational Study
por: Guarino, Maria, et al.
Publicado: (2020)

Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!
por: Guarino, Maria, et al.
Publicado: (2022)

Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
por: Belli, Valentina, et al.
Publicado: (2017)

Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
por: Guarino, Maria, et al.
Publicado: (2018)

Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life
por: Sabbatini, Massimo, et al.
Publicado: (2018)

Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells
por: Zappavigna, Silvia, et al.
Publicado: (2019)

Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures
por: Lama, Stefania, et al.
Publicado: (2019)

COVID-19 and Fatty Liver Disorders
por: Guarino, Maria, et al.
Publicado: (2023)

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
por: Sanduzzi-Zamparelli, Marco, et al.
Publicado: (2019)

PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial
por: Dallio, Marcello, et al.
Publicado: (2021)

Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis
por: Morisco, Filomena, et al.
Publicado: (2014)

Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial
por: Cossiga, Valentina, et al.
Publicado: (2019)

Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib
por: Sapena, Víctor, et al.
Publicado: (2022)

The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
por: Sanduzzi Zamparelli, Stefano, et al.
Publicado: (2023)

Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD
por: Di Mauro, Stefania, et al.
Publicado: (2021)

Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: a pilot case–control study
por: Morisco, Filomena, et al.
Publicado: (2018)

Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study
por: Federico, Alessandro, et al.
Publicado: (2015)

Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice
por: Invernizzi, Federica, et al.
Publicado: (2022)

Nasopharyngeal and Oropharyngeal Swabs, And/Or Serology for SARS COVID-19: What Are We Looking For?
por: Sanduzzi, Alessandro, et al.
Publicado: (2020)

Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?
por: Sanduzzi, Alessandro, et al.
Publicado: (2020)

Safety and immunogenicity of booster dose in patients with chronic liver disease
por: Cossiga, V., et al.
Publicado: (2023)

Safety and Immunogenicity of Anti-SARS-CoV-2 Booster Dose in Patients with Chronic Liver Disease
por: Cossiga, Valentina, et al.
Publicado: (2023)

Correlation between clinical-functional parameters and number of lobes involved in non-cystic fibrosis bronchiectasis
por: Giacon, Valeria, et al.
Publicado: (2021)

Skin Adverse Events During Dual and Triple Therapy for HCV-Related Cirrhosis
por: Federico, Alessandro, et al.
Publicado: (2014)

The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease
por: Federico, Alessandro, et al.
Publicado: (2020)

The Comparison of The Effects of Silybin and Silybin-Phosphatidylcholine on Viability and ESR Expression in Human Breast Cancer T47D Cell Line
por: Mahmoodi, Narges, et al.
Publicado: (2014)

Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability
por: Malaguarnera, Giulia, et al.
Publicado: (2016)

cis–trans Isomerization of silybins A and B
por: Novotná, Michaela, et al.
Publicado: (2014)

Effectiveness of Hepatitis B Vaccination Campaign in Italy: Towards the Control of HBV Infection for the First Time in a European Country
por: Stroffolini, Tommaso, et al.
Publicado: (2022)

Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*
por: Nahum, Méndez-Sánchez, et al.
Publicado: (2019)

Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents
por: Cossiga, Valentina, et al.
Publicado: (2022)

Humoral response to 2-dose BNT162b2 mRNA vaccine for COVID-19 in liver transplant recipients
por: Guarino, Maria, et al.
Publicado: (2022)

Silybin Modulates Collagen Turnover in an In Vitro Model of NASH
por: Anfuso, Beatrice, et al.
Publicado: (2019)

Proteomics study on the effect of silybin on cardiomyopathy in obese mice
por: Wang, Fei, et al.
Publicado: (2021)

Liver resection is always a good choice for hepatocellular carcinoma (HCC) patients regardless of Barcelona Clinic Liver Cancer (BCLC) stage: the therapeutic hierarchy
por: Guarino, Maria, et al.
Publicado: (2020)

CORRELATIONS BETWEEN VIRAL LOAD AND SYMPTOMS IN PATIENTS WITH COVID-19 PNEUMONIA
por: CAPITELLI, L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_leoovq3k4a6stfc9n4u5iu954r